-+ 0.00%
-+ 0.00%
-+ 0.00%

Gossamer Bio Q3 EPS $(0.21) Misses $(0.18) Estimate, Sales $13.294M

Benzinga·11/05/2025 21:31:41
Listen to the news

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.18) by 16.02 percent. This is a 50 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $13.294 million. This is a 40.23 percent increase over sales of $9.480 million the same period last year.